1. Home
  2. ICCC vs RETO Comparison

ICCC vs RETO Comparison

Compare ICCC & RETO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ICCC
  • RETO
  • Stock Information
  • Founded
  • ICCC 1982
  • RETO 1999
  • Country
  • ICCC United States
  • RETO China
  • Employees
  • ICCC N/A
  • RETO N/A
  • Industry
  • ICCC Biotechnology: Pharmaceutical Preparations
  • RETO Multi-Sector Companies
  • Sector
  • ICCC Health Care
  • RETO Consumer Discretionary
  • Exchange
  • ICCC Nasdaq
  • RETO Nasdaq
  • Market Cap
  • ICCC 28.0M
  • RETO 33.0M
  • IPO Year
  • ICCC 1987
  • RETO 2017
  • Fundamental
  • Price
  • ICCC $3.66
  • RETO $0.91
  • Analyst Decision
  • ICCC
  • RETO
  • Analyst Count
  • ICCC 0
  • RETO 0
  • Target Price
  • ICCC N/A
  • RETO N/A
  • AVG Volume (30 Days)
  • ICCC 14.5K
  • RETO 96.5K
  • Earning Date
  • ICCC 11-13-2024
  • RETO 12-26-2024
  • Dividend Yield
  • ICCC N/A
  • RETO N/A
  • EPS Growth
  • ICCC N/A
  • RETO N/A
  • EPS
  • ICCC N/A
  • RETO N/A
  • Revenue
  • ICCC $23,838,002.00
  • RETO $3,841,142.00
  • Revenue This Year
  • ICCC N/A
  • RETO N/A
  • Revenue Next Year
  • ICCC N/A
  • RETO N/A
  • P/E Ratio
  • ICCC N/A
  • RETO N/A
  • Revenue Growth
  • ICCC 46.37
  • RETO N/A
  • 52 Week Low
  • ICCC $3.34
  • RETO $0.86
  • 52 Week High
  • ICCC $5.59
  • RETO $6.50
  • Technical
  • Relative Strength Index (RSI)
  • ICCC 54.28
  • RETO 33.10
  • Support Level
  • ICCC $3.40
  • RETO $0.86
  • Resistance Level
  • ICCC $3.64
  • RETO $0.95
  • Average True Range (ATR)
  • ICCC 0.16
  • RETO 0.06
  • MACD
  • ICCC 0.01
  • RETO -0.01
  • Stochastic Oscillator
  • ICCC 65.12
  • RETO 17.24

About ICCC ImmuCell Corporation

ImmuCell Corp is engaged in the healthcare sector. The company operates in the development, acquisition, manufacture, and sale of products that improve the health and productivity of cows for the dairy and beef industries. The company operates in two business segment. The Scours segment is dedicated to manufacturing and selling First Defense, a product used to prevent scours in newborn calves, which is regulated by the United States Department of Agriculture (USDA). The Mastitis segment is focused on developing and commercializing Re-Tain, a product to treat subclinical mastitis in lactating dairy cows, which is regulated by the United States Food and Drug Administration (FDA). The company generates the majority of its revenue from the Scours segment.

About RETO ReTo Eco-Solutions Inc.

ReTo Eco-Solutions Inc is a manufacturer and distributor of eco-friendly construction materials and fly-ash, as well as equipment used to produce these eco-friendly construction materials. The company engaged in providing consultation, design, project implementation and construction of urban ecological environments for capturing, controlling and re-using rainwater. It operates through four segments namely Machinery and Equipment sales, Construction materials sales, Municipal Construction Projects, and Technology Consulting and other services. The company earns its revenue from Machinery and Equipment sales segment. Geographically, it derives a majority of its revenue from China.

Share on Social Networks: